Pilot Study Evaluation of 2 Artificial Tears. Evaluation of TBUT, Tear Meniscus Height and Tear Thickness

This study has been completed.
Information provided by:
Innovative Medical
ClinicalTrials.gov Identifier:
First received: May 2, 2007
Last updated: September 5, 2007
Last verified: September 2007

To determine baseline tear thickness and improvement immediately post installation of two artificial tear solutions:(9582X) and Allergan Refresh Tears.

Condition Intervention Phase
Tear Film Thickness
Drug: Refresh Tears, 9582X
Phase 4

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: Open Label

Further study details as provided by Innovative Medical:


Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both

Inclusion Criteria:

  1. Normal, healthy volunteers 18 years or older
  2. Males or females
  3. Any race or ethnic background

Exclusion Criteria:

  1. Corneal refractive surgery within 6 months of this study.
  2. Contact lens use on day of examination.
  3. Corneal ectasia
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00469521

United States, South Carolina
Magill Research Center Institute MUSC
Charleston, South Carolina, United States, 29425
Sponsors and Collaborators
Innovative Medical
Principal Investigator: Helga Sandoval, MS, MD Magill Research Center Institute MUSC
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00469521     History of Changes
Other Study ID Numbers: 5304
Study First Received: May 2, 2007
Last Updated: September 5, 2007
Health Authority: United States:Institution Review Board

ClinicalTrials.gov processed this record on April 17, 2014